|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2018-01-19 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2006-01-23 |
靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Goofice® in Patients With Chronic Constipation
This is a double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of Goofice® in patients with chronic constipation.
An Open-label, Randomized, Parallel-Group, Multi-Site Study to Evaluate the Efficacy and Safety of Azelastine HCl-Fluticasone Propionate Nasal Spray 137-50 mcg/Spray in Perennial Allergic Rhinitis Patients
The purpose of this study is to evaluate the efficacy and safety of Azelastine HCl-Fluticasone propionate Nasal Spray 137-50 mcg/spray compared to Dymista™ in patients with perennial allergic rhinitis
布地奈德气雾剂治疗成人支气管哮喘有效性和安全性的多中心、随机、盲法、阳性药物平行对照、非劣效临床试验
评价布地奈德气雾剂用于治疗成人支气管哮喘的有效性和安全性
100 项与 健乔信元医药生技股份有限公司 相关的临床结果
0 项与 健乔信元医药生技股份有限公司 相关的专利(医药)
100 项与 健乔信元医药生技股份有限公司 相关的药物交易
100 项与 健乔信元医药生技股份有限公司 相关的转化医学